Factor | Number | Univariate | Multivariate | ||||
---|---|---|---|---|---|---|---|
OR | 95%CI | P value | OR | 95%CI | P value | ||
Age (years) | |||||||
> 50 | 9 | 0.6 | 0.1–4.5 | 0.657 | |||
≤ 50 | 77 | ||||||
Anticryptococcal therapy | |||||||
Contained AmB | 53 | 0.4 | 0.0–3.7 | 0.405 | |||
Did not contain AmB | 34 | ||||||
HAART regimens | |||||||
Missing data | 29 | 1.8 | 0.4–7.9 | 0.454 | |||
INSTI | 21 | ||||||
Non-INSTI | 37 | ||||||
VPS placement | |||||||
Yes | 29 | 10.9 | 1.9–64.0 | 0.008 | 27.8 | 2.2–348.7 | 0.010 |
No | 57 | ||||||
CSF culture | |||||||
Missing data | 7 | ||||||
Positive | 54 | 2.9 | 0.7–11.7 | 0.127 | |||
Negative | 26 | ||||||
Blood culture | |||||||
Missing data | 1 | ||||||
Positive | 28 | 1.6 | 0.3–7.6 | 0.556 | |||
Negative | 58 | ||||||
Increase of CD4 count after 24 weeks(/mL) | |||||||
Missing data | 45 | ||||||
> 100 | 14 | 8.5 | 0.9–76.9 | 0.058 | 21.9 | 1.2–408.5 | 0.039 |
≤100 | 28 | ||||||
Initial CD4 count(/mL) | |||||||
Missing data | 28 | ||||||
> 20 | 26 | 0.3 | 0.1–1.4 | 0.112 | |||
≤ 20 | 33 | ||||||
Initial CSF ICH (mmH2O) | |||||||
Missing data | 5 | ||||||
> 300 | 52 | 1.4 | 0.3–5.9 | 0.633 | |||
≤ 300 | 30 | ||||||
Initial CD4 count (/mL) | |||||||
Missing data | 28 | ||||||
> 20 | 26 | 0.3 | 0.1–1.4 | 0.112 | |||
≤ 20 | 33 | ||||||
Initial CSF protein level (g/L) | |||||||
Missing data | 7 | ||||||
> 0.5 | 45 | 0.8 | 0.2–3.7 | 0.801 | |||
≤0.5 | 35 | ||||||
Initial CSF WBC (× 106/L) | |||||||
Missing data | 10 | ||||||
> 55 | 64 | 1.5 | 0.3–8.4 | 0.644 | |||
≤ 55 | 13 | ||||||
Time of HAART initiation | |||||||
Missing data | 35 | ||||||
Before 4 weeks | 27 | 3.6 | 0.3–38.2 | 0.282 | |||
After 4 weeks | 25 |